Expression of Biofilm-Related Genes in Extensively Drug-Resistant Acinetobacter baumannii

被引:1
|
作者
Khosravy, Maryam [1 ]
Hosseini, Farzaneh [2 ]
Razavi, Mohamad Reza [3 ]
Khavari, Ramazan Ali [1 ]
机构
[1] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[2] Islamic Azad Univ, Dept Biol, North Tehran Branch, Tehran, Iran
[3] Pasteur Inst Iran, Mol Parasitol Lab, Tehran, Iran
关键词
Acinetobacter baumannii; Pneumonia; Biofilm; XDR; IDENTIFICATION; INFECTION; PRODUCTS; STRAINS;
D O I
10.5812/jjm-133999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Acinetobacter baumannii is an important cause of nosocomial pneumonia in patients requiring long-term mechanical ventilation. Besides, extensively drug-resistant (XDR) strains cause infection in intensive care unit (ICU) patients. Chronic infections of A. baumannii and antimicrobial resistance are associated with biofilm formation. Several virulence genes, such as blaPER-1, pgaA, and bap, are involved in biofilm formation. Objectives: The current study examines the expression levels of biofilm formation-related genes in pneumonia patients. Methods: The sputum samples were collected from patients hospitalized in the ICU, and A. baumannii ATCC 19606, the reference strain, was isolated and cultured on blood agar, eosin methylene blue agar, and chocolate agar medium. The media were then incubated at 37 & DEG;C for 18 -24 hours. Next, Gram-Thirty XDR A. baumannii isolates were collected from the sputum samples of ICU patients at Besat Hospital in Tehran, Iran. Bacterial isolates were characterized for antibiotic resistance patterns and biofilm-forming ability. Subsequently, RNA was extracted from the biofilm-forming isolates. A real-time polymerase chain reaction (PCR) assay was performed to evaluate the expression levels of the blaPER-1, pgaA, and bap genes. Transcripts were normalized to 16S rRNA as an internal control, and gene expression fold changes were calculated. Statistical analysis was performed using an unpaired two-tailed t-test (P < 0.05) with SPSS (V. 16). Results: The disk diffusion susceptibility test revealed that all 30 (100%) isolates were resistant to piperacillin-tazobactam, cefepime, ceftriaxone, ceftazidime, gentamicin, imipenem, meropenem, levofloxacin, and ciprofloxacin. All 30 isolates from ICU-admitted patients (100%) were classified as XDR, and 27 (90%) isolates demonstrated the ability to form biofilms. The obtained results indicated a significant difference in gene expression levels. The fold change in expression for blaPER-1, bap, and pgaA was 7.473, 11.964, and 5.277, respectively. Conclusions: In our study, XDR A. baumannii primarily caused ventilator-associated pneumonia, and an observed increase in the expression of biofilm-related genes was noted in these strains. Healthcare centers should implement appropriate infection control programs to manage nosocomial infections, particularly in the ICU.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study
    Zheng, Yue
    Xu, Nana
    Pang, Jiaojiao
    Han, Hui
    Yang, Hongna
    Qin, Weidong
    Zhang, Hui
    Li, Wei
    Wang, Hao
    Chen, Yuguo
    FRONTIERS IN MEDICINE, 2021, 8
  • [22] Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin
    Chen, Fumei
    Deng, Xianyu
    Wang, Zhanpeng
    Wang, Li
    Wang, Ke
    Gao, Liang
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 241 - 247
  • [23] Nosocomial Outbreak of Extensively and Pan Drug-Resistant Acinetobacter baumannii in Tertiary Hospital in Central Part of Iran
    Japoni-Nejad, Alireza
    Sofian, Masoomeh
    van Belkum, Alex
    Ghaznavi-Rad, Ehsanollah
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2013, 6 (08)
  • [24] Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol
    Wei, Wen-juan
    Yang, Hai-fei
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 321 - 326
  • [25] First detection of a cefiderocol-resistant and extensively drug-resistant Acinetobacter baumannii clinical isolate in Bulgaria
    Strateva, Tanya
    Peykov, Slavil
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2024, 71 (01)
  • [26] A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
    Luna, B.
    Trebosc, V
    Lee, B.
    Bakowski, M.
    Ulhaq, A.
    Yan, J.
    Lu, P.
    Cheng, J.
    Nielsen, T.
    Lim, J.
    Ketphan, W.
    Eoh, H.
    McNamara, C.
    Skandalis, N.
    She, R.
    Kemmer, C.
    Lociuro, S.
    Dale, G. E.
    Spellberg, B.
    NATURE MICROBIOLOGY, 2020, 5 (09) : 1134 - 1143
  • [27] Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria
    Hoenigl, M.
    Drescher, M.
    Feierl, G.
    Valentin, T.
    Zarfel, G.
    Seeber, K.
    Krause, R.
    Grisold, A. J.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (03) : E88 - E90
  • [28] Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates
    Deolankar, Manas S.
    Carr, Rachel A.
    Fliorent, Rebecca
    Roh, Sean
    Fraimow, Henry
    Carabetta, Valerie J.
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [29] Antimicrobial efficacy of eravacycline against emerging extensively drug-resistant (XDR) Acinetobacter baumannii isolates
    Gautam, Hitender
    Raza, Shahid
    Biswas, Jaya
    Mohapatra, Sarita
    Sood, Seema
    Dhawan, Benu
    Kapil, Arti
    Das, Bimal K.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 48
  • [30] In vitro activity of antimicrobial agents against multidrug- and extensively drug-resistant Acinetobacter baumannii
    de Vasconcellos, Francielli Mahnic
    Tiba Casas, Monique Ribeiro
    Brisolla Tavares, Lais Calissi
    Garcia, Doroti de Oliveira
    Camargo, Carlos Henrique
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (01) : 98 - 102